Multiple Myeloma RefractoryPhase 2NCT07096778
Inobrodib, Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma
Inobrodib, Pomalidomide, Dexamethasone
182 Phase 2 studies recruiting right now, most recently updated first.
Open the Phase 2 page · a list of only those studies
Triangle is made by Triangle Health, Inc.
Leukemia, lymphoma, and myeloma182 studies
Multiple Myeloma RefractoryPhase 2NCT07096778
Inobrodib, Pomalidomide, Dexamethasone
Relapsed / Refractory AMLPhase 2NCT07710534
Decitabine-cedazuridine plus venetoclax (DEC-C+VEN), Azacitidine plus venetoclax (AZA+VEN)
Marginal Zone LymphomaPhase 2NCT05296070
Loncastuximab tesirine 150 µg/Kg, Loncastuximab tesirine 75µg/Kg
T-cell Acute Lymphoblastic LeukemiaPhase 2NCT06561074
Decitabine, Venetoclax, Calaspargase pegol-mknl
Hodgkin LymphomaPhase 2NCT05615636Papers
Mosunetuzumab, Polatuzumab vedotin, Tafasitamab, Lenalidomide
Chronic Lymphocytic Leukemia (CLL)Phase 2NCT07221500
NX-5948
Acute Myeloid LeukemiaPhase 2NCT05955261
Venetoclax, Azacitidine, Cytarabine, Gemtuzumab Ozogamicin
Acute Myeloid LeukemiaPhase 2NCT04282187
Decitabine, Ruxolitinib, Fedratinib, Questionnaire Administration
Acute Myeloid LeukemiaPhase 2NCT06824168
Quizartinib High Dose, Quizartinib Low Dose
SplenomegalyPhase 2NCT06345495
Ruxolitinib, Allogeneic Stem Cell Transplantation, Levetiracetam, Eltrombopag
Acute Monocytic LeukemiaPhase 2NCT06504459
Azacitidine, Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy
T-cell Acute Lymphoblastic LeukemiaPhase 2NCT05289687Papers
Daratumumab / Hyaluronidase Injection
Acute Bilineal LeukemiaPhase 2NCT03683433Papers
Azacitidine, Enasidenib Mesylate
Multiple Myeloma in RelapsePhase 2NCT06827860
Talquetamab, Daratumumab
Myeloma MultiplePhase 2NCT07085728
Cyclophosphamide, Bortezomib (VELCADE), Dexamethasone, Daratumumab-hyaluronidase
Blastic Plasmacytoid Dendritic Cell NeoplasmPhase 2NCT04216524
Cyclophosphamide, Cytarabine, Dexamethasone, Doxorubicin
Myelodysplastic SyndromesPhase 2NCT06566742
Olutasidenib
LeukemiaPhase 2NCT06229912
Revumenib
CTCLPhase 2NCT06854653
PTX-100
Advanced Hodgkin LymphomaPhase 2NCT06745076
Biospecimen Collection, Computed Tomography, Dacarbazine, Doxorubicin
Recurrent Mantle Cell LymphomaPhase 2NCT07003295
Biospecimen Collection, Computed Tomography, Glofitamab, Obinutuzumab
Recurrent Classic Hodgkin LymphomaPhase 2NCT05039073
Brentuximab Vedotin, Hematopoietic Cell Transplantation, Nivolumab, Quality-of-Life Assessment
Severe Aplastic Anemia (SAA)Phase 2NCT03520647
Cyclophosphamide, Peripheral Blood Stem Cells
Follicular LymphomaPhase 2NCT06043323
Axicabtagene Ciloleucel, Cyclophosphamide, Fludarabine phosphate, Prednisone